Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00687414 · ClinicalTrials.gov registry record
Evaluation of Formin Gene Status and Expression in Myeloproliferative and Myelodysplastic Disorders
A clinical trial, sponsored by Corewell Health West.
- Completed
- Registry status
- 60
- Enrollment target
NCT00687414: Completed study, sponsored by Corewell Health West.
NCT00687414 is a clinical trial that has completed, run by Corewell Health West. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00687414 has completed, sponsored by Corewell Health West.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
Aim of the study is to analyze the expression of genes and sequences encoding the human mammalian diaphanous (mDia) related formin proteins to test the hypothesis that defects in the mDia expression or function might drive the pathophysiology of myelodysplastic syndrome, acute myeloid leukemia and other myeloproliferative diseases.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2008-04 |
| Est. Completion | 2010-01 |
What the finished NCT00687414 record still lists
NCT00687414 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00687414 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00687414 about?
NCT00687414 is a clinical study titled "Evaluation of Formin Gene Status and Expression in Myeloproliferative and Myelodysplastic Disorders". Aim of the study is to analyze the expression of genes and sequences encoding the human mammalian diaphanous (mDia) related formin proteins to test the hypothesis that defects in the mDia expression or function might drive the pathophysiology of myelodysplastic syndrome, acute myeloid leukemia and o...
What is the current status of trial NCT00687414?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2008-04. Estimated completion is 2010-01.
Who is sponsoring clinical trial NCT00687414?
This trial is sponsored by Corewell Health West, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia